Bath & Body Works (NYSE:BBWI – Get Free Report) is expected to post its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Bath & Body Works to post earnings of $2.04 per share and revenue of $2.78 billion for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter last year, the company earned $0.48 earnings per share. Bath & Body Works’s revenue for the quarter was up 3.1% on a year-over-year basis. On average, analysts expect Bath & Body Works to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Bath & Body Works Stock Up 3.6 %
Shares of NYSE:BBWI opened at $39.99 on Tuesday. Bath & Body Works has a 52-week low of $26.20 and a 52-week high of $52.99. The company has a 50 day moving average of $37.73 and a two-hundred day moving average of $33.96. The company has a market capitalization of $8.66 billion, a price-to-earnings ratio of 9.75, a price-to-earnings-growth ratio of 0.92 and a beta of 1.83.
Bath & Body Works Announces Dividend
Analysts Set New Price Targets
A number of research firms have recently weighed in on BBWI. Telsey Advisory Group reissued an “outperform” rating and set a $43.00 price target on shares of Bath & Body Works in a research report on Thursday, February 20th. Argus reissued a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. Barclays raised shares of Bath & Body Works from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $34.00 to $43.00 in a research report on Monday. Morgan Stanley decreased their price target on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Six equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $44.19.
View Our Latest Stock Analysis on Bath & Body Works
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Stories
- Five stocks we like better than Bath & Body Works
- How to Invest in Biotech Stocks
- Finding Hidden Gems: Unconventional Penny Stock Investing
- 3 Stocks to Consider Buying in October
- Price Targets on NVIDIA Rise in Front of Earnings
- What Are Dividends? Buy the Best Dividend Stocks
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.